Impact of human immunodeficiency virus on pulmonary vascular disease.

Kumar, Ashok; Mahajan, Aatish; Salazar, Ethan A; Pruitt, Kevin; Guzman, Christian Arce; Clauss, Matthias A; Almodovar, Sharilyn; Dhillon, Navneet K

Kumar, Ashok; Mahajan, Aatish; Salazar, Ethan A; Pruitt, Kevin; Guzman, Christian Arce; Clauss, Matthias A; Almodovar, Sharilyn; Dhillon, Navneet K.

Afiliação

Kumar A; Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Mahajan A; Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.
Salazar EA; Department of Immunology & Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Pruitt K; Department of Immunology & Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Guzman CA; Pulmonary, Critical Care, Sleep & Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Clauss MA; Pulmonary, Critical Care, Sleep & Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Almodovar S; Department of Immunology & Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
Dhillon NK; Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

Glob Cardiol Sci Pract ; 2021(2): e202112, 2021 Jun 30.

Article em En | MEDLINE | ID: mdl-34285903

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Glob Cardiol Sci Pract Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google